BioCardia, Inc. Inventory, Finished Goods, Net of Reserves
BioCardia, Inc. (BCDA) had Inventory, Finished Goods, Net of Reserves of $4.00 thousand as of 2019-12-31, per its 10-K filed 2021-03-30.
Discontinued › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2021-03-30
- 2019-12-31: Inventory, Finished Goods, Net of Reserves $4.00K.
- 2019-06-30: Inventory, Finished Goods, Net of Reserves $5.00K.
- 2019-03-31: Inventory, Finished Goods, Net of Reserves $9.00K.
- 2018-12-31: Inventory, Finished Goods, Net of Reserves $23.00K.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2019-12-31 | $4.00K 10-K · filed 2021-03-30 |
| 2019-06-30 | $5.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $9.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $23.00K 10-K · filed 2020-04-09 |
| 2018-09-30 | $69.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $44.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $55.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $29.00K 10-K · filed 2019-04-02 |
| 2017-09-30 | $79.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $115.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $43.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $76.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $529.00K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |